RecruitingNot ApplicableNCT06981065

The Scandinavian Displaced Lateral Clavicle Trial

The Scandinavian Displaced Lateral Clavicle Trial (ScanDiLaC) - A Multicentre, Pragmatic, 12-Month, Non-inferiority, Randomized Controlled Trial


Sponsor

Uppsala University

Enrollment

96 participants

Start Date

Sep 17, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

A multicentre multinational RCT to investigate whether non-surgical treatment is non-inferior to surgical treatment for displaced extraarticular lateral clavicle fractures in adults.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria1

  • \- Displaced extraarticular lateral clavicle fracture (type II or V according to the modified Neer classification)

Exclusion Criteria8

  • Pathological fracture
  • Open fracture
  • Neurovascular injury
  • Same-time fracture in the upper extremity
  • Polytrauma
  • Contraindications to surgery and/or anesthesia
  • Unable to give informed consent
  • Inability to complete follow-up

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURESimple Sling and Physiotherapy

Non-surgical treatment with a simple sling and physiotherapy according to standardized program.

PROCEDURESurgical treatment

Surgical treatment with plate and screws (lateral clavicle plate, clavicle plate or hook plate with/without coracoclavicular fixation).


Locations(11)

Odense University Hospital

Odense, Denmark

Tampere University Hospital

Tampere, Finland

Østfold Hospital Trust

Fredrikstad, Norway

Kalmar Regional Hospital

Kalmar, Sweden

Linköping University Hospital

Linköping, Sweden

Skane University Hospital

Malmo, Sweden

Örebro University Hospital

Örebro, Sweden

Danderyd Hospital

Stockholm, Sweden

Stockholm South Hospital

Stockholm, Sweden

Norrlands University Hospital

Umeå, Sweden

Uppsala University Hopsital

Uppsala, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06981065


Related Trials